Slingshot members are tracking this event:
Loxo Oncology Receives Breakthrough Therapy Designation from FDAfor LOXO-101
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Jul 13, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Loxo-101, Breakthrough Therapy Designation, Metastatic Solid Tumors, Ntrk-fusion Proteins